Company Introduction
Guangdong Chuangmei Anti-aging Research Institute is a domestic technological innovation and scientific research service platform for the aesthetic industry initiated by the industry giants and many scientists at home and abroad. Our aim is to provide innovative technology (products) for American enterprises. Orientation is a technology transfer platform for transforming innovative technology into innovative products.
Chuangmei Anti-Aging Research Institute invested 100 million yuan in the first phase to establish a 2400 square meters GMPC standard research and development room. It has 42 PhD and 60 PhD research teams in biochemical industry. It has more than 500 patented technologies in reserve and 32 core technologies. It has passed 7 patented technologies. There are four production bases, providing services for 2783 brands at home and abroad.
We are committed to becoming the highest, broadest and deepest technological platform in the global cosmetics industry, constantly innovating and enhancing the core competitiveness of the beauty brand. By establishing an international cross-cutting R&D team, continuously introducing or independently developing world-class technology, reserving technology, formulation and proprietary raw materials, we can provide the following services for the industry:
1. OEM/ODM One-stop Cosmetics Processing Service
2. Provide customers with R&D and customized product formulation planning to enhance the core competitiveness of customers'products;
3. Technology export and patent export;
4. Supply of special functional raw materials;
5. Clinical testing, patent declaration, scientific research project declaration and scientific research personnel training.
6. Supply Chain Finance
On September 3, 2017, the Academy officially announced its establishment to the industry at the 47th China (Guangzhou) International American Expo Conference Forum.
On September 7, 2017, seven representatives of sponsoring shareholders completed the signing ceremony for shareholders of the Academy.
On December 8, 2017, Liu Gangyong, professor of Guangdong Food and Drug Vocational and Technical College and President of Guangdong Cosmetics Science and Technology Research Association, was successfully approached to invite consultants of the Institute and explore ways of cooperation.
On December 30, 2017, an agreement was formally reached with Professor Yin Yanwei of the National "Hundred People Program" to include the stem cell transplantation project in the Research Institute project.
In January 2018, a formal cooperation agreement was reached with Professor Hui Hongxiang.
On March 26, 2018, Chuangmei Research Institute welcomed the strategic investment of Aibai Group.
From July 15 to 16, 2018, Chuangmei Anti-aging Research Institute unveiled the 2018 China Cosmetic Supply Chain Exhibition.
On September 7, 2018, Hanhu Cosmetics Co., Ltd. joined Guangdong Chuangmei Anti-aging Research Co., Ltd.
In December 2018, 1000 square meters of stem cell preparation center was completed.
On December 13, 2018, Chuangmei Anti-Aging Research Institute and Beijing Taiai Peptide Group, the global giant of peptide production, reached strategic cooperation.
On January 17, 2019, Chuangmei Research Institute held its opening conference.
The objectives of Chuangmei Research Institute in 2019 are:
1. Establish branches in New York, Seoul, Korea and Bologna, Italy.
2. Establish an international cross-cutting R&D team with more than 100 people and reserve 30 world-class innovative technologies.
3. Establish the Infant Skin Care Research Institute jointly with Israel's largest chemical enterprise.
4. Establish a factory for the production of liposome wrapping, a functional raw material for cosmetics.
5. Build a global supply chain platform for high-quality raw material suppliers and shared factories for domestic brands.
Chuangmei Research Institute attaches great importance to R&D and product standardization, and cooperates with the government to establish relevant standards. Create a high-tech cosmetics industry and the industry's iconic industry R&D platform. Improve the level of innovation in the aesthetic industry, change the impression of homogeneity and low quality in the aesthetic industry, and hope to become a business card of innovation in the aesthetic industry. Our goal is to become the first domestic R&D platform to enter the capital market in 2022. Through technological innovation and standard-setting, we can help the development of Chinese brands.